Ropinirole Hydrochloride

CHEMBL1200411 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
296.8 g/mol
LogP
Phase
4

The hydrochloride salt formulation of ropinirole used to manage motor symptoms in Parkinson's disease and to relieve the uncomfortable urges to move associated with restless legs syndrome. Extended-release formulations allow for convenient once-daily dosing.

分子量

296.8300 g/mol

TPSA

32.30 Ų

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCN(CCC)CCc1cccc2c1CC(=O)N2.Cl

InChI

InChI=1S/C16H24N2O.ClH/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15;/h5-7H,3-4,8-12H2,1-2H3,(H,17,19);1H

Molecular Formula

C16H25ClN2O

HBD / HBA

2 / 2

回転可能結合数

7

重原子数

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

The hydrochloride salt formulation of ropinirole used to manage motor symptoms in Parkinson's disease and to relieve the uncomfortable urges to move associated with restless legs syndrome. Extended-release formulations allow for convenient once-daily dosing.

Yes, Ropinirole Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200411. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 68727. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.